In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
US11337994B2 · kind B2 · utility
1Cited by
26References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2017 |
| Grant date | May 24, 2022 |
| Priority date | — |
| Expiry date | Sep 14, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/78
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are in situ gelling compositions. The compositions include an anti-inflammatory polysaccharide and a gelling polymer, wherein the composition is a liquid prior to administration to a subject but converts to a gel upon administration to the subject. The compositions described herein have numerous applications with respect to the local treatment (reduction or prevention) of inflammation and/or tissue damage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.